See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days

News Digest / Ticker: NVS

Ticker: NVS

03:53am, Friday, Mar 27, 2026

Novartis Sets Sights on Excellergy with $2 Billion Acquisition Deal

Novartis is planning to acquire U.S. biotech firm Excellergy for up to $2 billion, boosting its immunology portfolio with a focus on food allergy treatments. The deal complements recent acquisitions, marking a robust biotech expansion strategy.

04:44am, Tuesday, Oct 28, 2025

Novartis CEO Signals Ongoing Big-Money M&A Moves with $12B Avidity Buy

09:09am, Thursday, Jun 26, 2025

Incyte's New CEO Bill Meury Sparks 3.6% Stock Surge: A Promising Shift for Investors

06:52am, Friday, Jun 13, 2025

Novo Nordisk Rises to the Top: What Traders Need to Know About the Leadership Change and Market Opportunities

10:07am, Monday, May 12, 2025

Novartis Champions Global Health Amid Funding Cuts: A Promising Prospect for Investors

03:22am, Wednesday, Apr 23, 2025

Pharma Giants Push for Higher Drug Prices: What It Means for Traders and Market Dynamics

06:37am, Tuesday, Apr 22, 2025

Earnings Watchlist for Traders: Tesla, Google & Consumer Giants Take the Stage

T

03:44am, Monday, Feb 24, 2025

Amgen Invests $200 Million in New Biotech Hub in India: What This Means for Traders and the Future of Pharma Innovation

06:14am, Thursday, Nov 21, 2024

Novartis Boosts Sales Growth Outlook, Sparking Optimism Amid Patent Expiration Concerns

08:44am, Tuesday, Oct 29, 2024

Major Companies Set to Report Earnings Today: What Investors Need to Know

08:30am, Friday, Jul 26, 2024

Building a Balanced Portfolio: A Comprehensive Guide with a Focus on High-Quality Dividend Stocks

B